February 15th marks International Angelman Day. This date was chosen symbolically, as the disorder is associated with the 15th chromosome. The goal of this day is to raise public awareness about this rare genetic condition and to provide support for affected families.
Angelman Syndrome (AS) is a neuro-genetic condition caused by a loss of function of the UBE3A gene located on the 15th chromosome. The disorder is characterized by significant developmental delays, speech difficulties, and impairments in balance and motor skills. Specific behavioral traits are also hallmarks of the syndrome, such as frequent smiling, laughter, and an excitable personality, manifesting in a remarkably positive demeanor.
The history of Angelman Syndrome began in 1965, when British pediatrician Harry Angelman first described the condition. Later, in the 1980s and 90s, genetic research confirmed that the syndrome is caused by a deficiency of the maternal UBE3A gene on chromosome 15, providing a scientific foundation and paving the way for modern diagnostic methods.
Currently, there is no cure for the syndrome; however, scientists are actively working on gene therapy, which may be able to restore the function of the affected gene in the future.
Early intervention is crucial: physical therapy, alternative communication methods, and behavioral therapy play a decisive role in helping individuals with Angelman Syndrome integrate into society and improve their quality of life.
